News on protein analysis, clinical proteomics, biomarkers in genetics, genomics, and molecular diagnostics.
The researchers established the suitability of FraC nanopores for protein analysis and offered a new approach to driving proteins into nanopores for detection.
A review by Max Planck researcher Matthias Mann and colleagues suggests that improved mass spec performance could enable more effective plasma marker discovery.
A University of Graz team used a protein interaction-based proteogenomic approach to study the effect of mutations on the eight components of the BBSome complex.
The researchers are now working with Chinese collaborators to license the markers in that country and launch clinical studies of their utility for lung cancer detection.
The researchers combined different proteomic methods to explore the activity of the ALK inhibitor ceritinib and identify potential combination therapies.
A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.
UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.
Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.
In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.